Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

68.59
+2.213.33%
Pre-market: 68.25-0.3400-0.50%05:10 EDT
Volume:1.83M
Turnover:125.66M
Market Cap:8.94B
PE:-116.58
High:69.67
Open:67.40
Low:67.00
Close:66.38
52wk High:69.67
52wk Low:11.16
Shares:130.29M
Float Shares:118.00M
Volume Ratio:0.75
T/O Rate:1.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5884
EPS(LYR):-0.3490
ROE:-9.40%
ROA:-5.05%
PB:10.83
PE(LYR):-196.50

Loading ...

10x Genomics : Deutsche Bank Raises Target Price to $30 From $23

THOMSON REUTERS
·
Jun 03

A Look At 10x Genomics (TXG) Valuation After A Strong Year Of Share Price Momentum

Simply Wall St.
·
Jun 02

10x Genomics CEO Serge Saxonov sells USD 705,273 of Class A shares

Reuters
·
May 28

Is It Time To Reassess 10x Genomics (TXG) After Its 188% One Year Share Price Surge

Simply Wall St.
·
May 21

Citi hires Jaschke to lead West Coast life sciences tools M&A coverage

Reuters
·
May 21

10x Genomics Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 13

Morgan Stanley Lifts Price Target on 10x Genomics to $22 From $20, Keeps Equalweight Rating

MT Newswires Live
·
May 12

U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis

Reuters
·
May 12

Stock Track | 10x Genomics Plummets 8.52% Intraday After Q1 Report Shows Revenue Decline and License Revenue Plunge

Stock Track
·
May 08

Piper Sandler Keeps Their Hold Rating on 10x Genomics (TXG)

TIPRANKS
·
May 08

10x Genomics (TXG) Receives a Buy from Barclays

TIPRANKS
·
May 08

Stock Track | 10x Genomics Plunges 6.33% in Pre-Market Despite Earnings Beat as Revenue Declines and Analysts Revise Estimates

Stock Track
·
May 08

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and Telix Pharmaceuticals (OtherTLPPF)

TIPRANKS
·
May 08

10x Genomics Q1 EPS $(0.10) Beats $(0.30) Estimate, Sales $150.843M Beat $146.355M Estimate.

Benzinga Earnings
·
May 08

10x Genomics Q1 net loss narrows to $13.5 million; revenue drops 3% to $150.8 million

Reuters
·
May 08

BRIEF-10X Genomics Q1 Revenue USD 150.8 Million Vs. IBES Estimate USD 146.4 Million

Reuters
·
May 08

10x Genomics Inc: Maintaining Its Full Year 2026 Revenue Guidance

THOMSON REUTERS
·
May 08

10x Genomics Inc - Q1 2026 Revenue Excludes One-Time License and Royalty Revenue

THOMSON REUTERS
·
May 08

Press Release: 10x Genomics Reports First Quarter 2026 Financial Results

Dow Jones
·
May 08

Does Atera’s New Spatial Biology Platform Change The Bull Case For 10x Genomics (TXG)?

Simply Wall St.
·
May 02